After Hours Summary: WFM +3% following earnings/guidance and dividend/buyback/CFO news... SNAP -23%, MNKD -19%, SYMC -7%, ELF -6% following earnings/guidanceAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: SGMO +42.5% (also announced strategic collaboration with Pfizer), RELY +26.5%, PEGA +11.4%, XONE +10.5%, SCLN +4.6%, PFIE +4.5% (light volume), LPSN +4.4% (ticking higher), WFM +3.2% (also increases dividend, announces share repurchase; updates strategic initiations; names new CFO), ASM +3.2% (light volume), XON +2.8%, VUZI +2.7%, AYX +2.5%, RLGT +2.3%, ATH +2.3%, OMER +2.2%, DRYS +2.1%, EEP +2%, INO +1.7%, PCYG +1.2%, IOTS +1% (thinly traded), WATT +1%
Companies trading higher in after hours in reaction to news: PED +50.5% (continued strength - filed 10-Q and regained NYSE compliance today), MRK +3.1% (confirms FDA approval of KEYTRUDA (pembrolizumab) as first-line combination therapy with pemetrexed and carboplatin for patients with metastatic NSCLC irrespective of PD-L1 expression), NMM +2.3% (light volume; provides update for acquisition of 14-Vessel container fleet from Rickmers Maritime), ORLY +1% (to increase the authorization amount under its share repurchase program by an additional $1 billion, raising the aggregate authorization under the program to $8.75 billion)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: NH -24.4%, SNAP -23.2%, MNKD -18.8%, BCEI -16.8% (ticking lower), KGJI -16.7%, RGSE -16.3%, AVNW -16%, FRSH -11.8%, RESN -11.5% (light volume), NYRT -9.7%, NVCN -7.9%, HOLX -7.5%, SYMC -7.2%, ELF -6.2%, ANTH -6.2%, QUIK -4.2%, RUN -3.3%, IMMU -2.6%, STML -2.5% (light volume), AMBC -1.8%
Companies trading lower in after hours in reaction to news: ITUS -35.3% (proposed registered public offering of its common stock), CNAT -14.8% (to offer and sell shares of its common stock in an underwritten public offering), MTBC -4.6% (announces $2.3 mln registered direct offering at $2.30 per share), SP -4.6% (announces certain existing stockholders intend to offer for sale 3.6 mln shares of its common stock in a secondary offering), ABR -3.3% (plans to make a public offering of 9,500,000 shares of its common stock), BCRX -1.8% (files for 11,710,951 share common stock offering by holders), CVTI -1.1% (US District Court for the Southern District of Ohio issued a pre-trial decision against one of its subsidiaries relating to a cargo claim incurred in 2008; co is reviewing its options regarding further appeals), MEOH -1.1% (initiated with Underperform at Bernstein; tgt $36), USFD -0.7% (commences 35 mln common stock offering by Clayton, Dubilier & Rice and KKR and certain members of management and the board)
![]()
- Post-earnings gainers: SGMO +46%, PEGA +6.9%, IOTS +6.7%, LPSN +4.4%, CUR +4%, ASYS +3.3%, DRRX +3%, VSTM +2.5%, RLGT +2.3%, WFM +2.1%
- Post-earnings losers: NH -41.9%, SNAP -24.3%, RGSE -20%, BCEI -19.4%, FRSH -13.8%, MNKD -11.9%, AVNW -9.7%,SYMC -6.8%, NVCN -6.1%, GALE -5.5%, ANTH -4.9%, ELF -4.6%, FOXA -4.3%, AGTC -2.5%
Closing Market Summary: Another Day, Another Flat FinishThe S&P 500 (+0.1%) finished at a new record close (just barely), but the headline is much more exciting than the reality. Wednesday's session was rather quiet at the macro level with the benchmark index hovering within a seven-point range. The Nasdaq (+0.1%) also eked out another record close, its third of the week, while the Dow (-0.2%) settled a step below its unchanged mark. The Russell 2000 outperformed the major U.S. indices, adding 0.6%.
Investors shrugged off President Trump's unexpected firing of FBI director James Comey, even though some mainstream media outlets suggested that the event may forestall tax reform efforts. The CBOE Volatility Index (VIX 9.99, +0.03, +0.3%) remained at a historically low level at Wall Street's closing bell.
Crude oil's 3.1% advance secured the energy sector's (+1.1%) spot atop the day's leaderboard. The commodity rallied following the Energy Information Administration's weekly inventory report, which showed a larger than expected draw in U.S. crude stocks for the week ended March 5 (5.3 million barrels actual vs 2.0 million barrels consensus). WTI crude settled at $47.28/bbl.
Out of the ten remaining sectors, seven--financials (+0.3%), materials (+0.4%), technology (+0.4%), consumer staples (+0.1%), utilities (+0.2%), telecom services (+0.3%), and real estate (+0.6%)--finished in the green. The top-weighted technology sector's positive performance was underpinned by chipmakers, which rallied around NVIDIA's (NVDA 121.29, +18.35) upbeat earnings report. The company spiked 17.8% after reporting better than expected earnings/revenues and issuing positive guidance. The PHLX Semiconductor Index added 2.1%.
Conversely, the three laggards--consumer discretionary (-0.3%), industrials (-0.4%), and health care (-0.3%)--received no help on the earnings front. Walt Disney (DIS 109.66, -2.41) and Priceline (PCLN 1824.77, -86.36) weighed on the consumer discretionary sector, losing 2.2% and 4.5%, respectively. Both companies reported better than expected earnings, but PCLN missed top-line estimates and issued disappointing guidance.
Allergan (AGN 229.72, -8.79) was the worst-performing component in the health care sector, tumbling 3.7%, despite reporting upbeat earnings/revenues and providing positive guidance. Analysts at Goldman did downgrade AGN shares to 'Neutral' from 'Buy' on Wednesday morning, which contributed to the company's poor performance. Biotech names also weighed on the sector, evidenced by the 0.4% decrease in the iShares Nasdaq Biotechnology ETF (IBB 291.89, -1.06).
In the industrial sector, Boeing (BA 183.18, -2.31) took center stage following reports that the company halted 737 MAX flights for engine inspections. BA shares finished lower by 1.3%.
U.S. Treasuries hovered just above their flat lines for the majority of Wednesday's session, however, a late-afternoon downtick took them into the red. The benchmark 10-yr yield settled one basis point higher at 2.41%.
On the data front, investors received April Import/Export Prices, the April Treasury Budget, and the weekly MBA Mortgage Applications Index:
- Import prices excluding oil rose 0.3% in April after adding 0.2% in March. Export prices excluding agriculture increased 0.1% in April after rising 0.1% in March (revised from 0.2%).
- The key takeaway from the report is that it won't alter the market's current assumptions about the likely path of the Fed's monetary policy.
- The Treasury Budget for April showed a surplus of $182.4 billion versus a surplus of $106.5 billion for April 2016.
- The Treasury Budget data is not seasonally adjusted, so the April surplus cannot be compared to the $176.2 billion deficit registered in March.
- The weekly MBA Mortgage Applications Index increased 2.4% to follow last week's 0.1% downtick.
Tomorrow, market participants will receive April PPI (consensus 0.2%) and Initial Claims (consensus 242,000). Both reports will cross the wires at 8:30 ET.
- Nasdaq Composite +13.9% YTD
- S&P 500 +7.2% YTD
- Dow Jones Industrial Average +6.0% YTD
- Russell 2000 +3.1% YTD
![]()
Snap misses by $0.26 (GAAP), misses on revs (22.97 -0.35)
|
Early premarket gappersGapping up:
- ESIO +23.5%, MNKD +18.8%, ANF +15.6%, ARRY +14.5%, SEDG +14.2%, RCM +14.1%, NVDA +12.1%, CUR +10.9%, ATHX +10.8%, REXX +10.6%, NAVB +9.8%, VSLR +8.8%, COHR +8.7%, EA +8.3%, HPJ +8.2%, COTY +7.6%, MTBC +7.1%, OCRX +7%, TRIP +6.2%, FAC +5.9%, VCEL +5.9%, IAG +5.6%, TRUE +5.4%, FBM +5.3%, AAXN +5.2%, CROX +5.2%, MCHP +4.9%, GSVC +4.6%, NBIX +4.4%, HEAR +4.3%, RPD +4.2%, GFI +3.8%, XELB +3.7%, AGI +3.5%, XOG +3.5%, CLDX +3.2%, SLD +3%, AMD +2.9%, YUME +2.8%, WIX +2.8%, SBGL +2.7%, NUAN +2.7%, YY +2.6%, BID +2.4%, EVRI +2.3%, AU +2%, ING +2%, TRCO +1.9%, GDX +1.6%, INGN +1.6%, AUXO +1.5%, ABX +1.4%, GDOT +1.4%, ATHM +1.4%, HPT +1.4%, BBL +1.2%, RIO +1.2%, BHP +1.1%, LEU +1.1%, INFI +1.1%, NVO +1%, HSBC +1%
Gapping down:
- YELP -26.7%, FOSL -22.9%, PLPM -16.7%, KRNT -15.9%, ACIA -13.8%, DEPO -13.5%, FUEL -12.3%, EKSO -10.5%, SSNI -10.4%, CLNT -10.1%, OPK -9.7%, TCX -9.5%, ZAYO -7.3%, TIME -6.6%, COGT -6.3%, EARN -5.7%, ZSAN -5.5%, MTRX -5.5%, SPWR -5.3%, MZOR -5.3%, ARNA -4.7%, XCO -4.7%, HALO -4.6%, AQMS -4.6%, DPW -4.5%, INN -4.2%, RICK -4.1%, ITEK -4.1%, ACAD -3.9%, PRI -3.8%, CXRX -3.7%, OREX -3.5%, AKBA -3.5%, AMID -3.5%, PCLN -3.2%, MATR -3.2%, JAZZ -3.1%, PEIX -2.9%, WSTC -2.5%, MIDD -2.5%, EGLT -2.4%, GERN -2.3%, X -2.1%, DIS -2.1%, SLF -1.7%, LSCC -1.6%, SAGE -1.6%, OCLR -1.5%, COKE -1.5%, CLNS -1.4%, AGN -1.3%, AGN -1.3%, PSEC -1.3%, SUPN -1.2%, W -1.1%, WFC -1.1%, WAIR -1.1%, LITE -1%, IPHI -1%, GWPH -1%
May 10, 2017
MAKOR - WIX (Wix.com) 1Q17 results - Record Premium subscriptions adds; FY17 guidance is raised - first take;
• Revenues for 1Q17 of $92.5m above street consensus of $90.4m, an increase of 50% compared with 1Q16 and 10% sequentially. 1Q17 collections increased by 51% compared with 1Q16 and 17% sequentially.• Record Premium subscriptions additions - added 208k net premium subscriptions in the period to reach 2.7 million as of March 31, 2017, a 38% increase over the prior year (in 1Q16 the company added 170k premium subscriptions). Positive momentum in the users cohorts continues.• Registered user growth – the company added 5.9 million registered users in the first quarter to reach 103 million as of March 31, 2017, a 25% increase compared to the prior year;• Free Cash Flow for 1Q17 of $14.8m above street expectation of $12.9m (and vs $ -2.1m in 1Q16), reflecting the continued strong operational leverage of the business.• Non GAAP loss per share of ($0.18) below street consensus of (-$0.13).• 2Q17 guidance – management guides 2Q revenues in the range of $101-$102 slightly above street consensus of $100.6m (47.5% y/y growth at mid-point), and collections in the range of $116-$117 million (43% y/y growth at mid-point)• FY2017 guidance is raised – management raises full year guidance and expects revenues in the range of $421m-$423m (up from $417m-$419m) above street consensus of $419m, collections in the range of $473m-$477m (up from $461m-$467m ) and Non GAAP free cash flow in the range of $67-$68 million (up from $63-$64 million).• The company plans to launch a closed beta of a new major product in June and publicly reveal the product in the following months.• Management will host a call at 8:30 a.m. ET. We expect management to provide more details regarding current business trends and new products launch.Dial number: 866-393-4306 (US/Canada), 734-385-2616 (International) or 1-809-315-362 (Israel).We currently have a Hold rating on WIX with $64 PT (current price $74.15) - Update to follow.
Makor Capital11 Menachem Begin St., 26th FLRamat Gan 52681
ISRAEL
Tel +972 3 5453 762Fax +972 3 7162 680Research DisclaimerThis publication has been prepared by Makor Capital Limited (“Makor Capital”) and is intended for professional or qualified investors only. Makor Securities London Ltd (“Makor Securities”)is distributing this material to its clients who are Eligible Counterparties or Professional Clients under FCA Rules. It may also be disseminated to persons who are Investment Professionals within the meaning of the Financial Services and Markets Act 2000 (Financial Promotion Order 2005). In the United States, Makor Capital only distributes this material to major US institutional investors (as that term is defined in Rule 15a-6 of the Securities and Exchange Act of 1934) and to SEC-registered broker-dealers or banks acting in a broker–dealer capacity. This material is not intended for distribution to any other persons and should not be redistributed. If you do not fall into any of these categories you should disregard it.This material is a marketing communication. It is not investment research and has not been prepared in accordance with legal requirements designed to promote the independence of investment research. It is not subject to any prohibition on dealing ahead of the dissemination of investment research under U.K. law. This material is not a research report and is not intended to be a research report as defined under U.S. securities laws and regulations. This material is not intended to provide information reasonably sufficient upon which to base any investment decision.This material does not take into account the particular investment objectives, financial situation or needs of individual clients or other recipients. Before acting on this material, clients and other recipients should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice.This material should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action.In the United States, Makor Capital does not offer securities services to U.S. persons except pursuant to SEC Rule 15a-6 only to major US institutional investors and SEC registered broker-dealers or banks acting in a broker–dealer capacity. Transactions in the United States must be effected through the U.S. broker-dealer, Oscar Gruss & Son Incorporated. Oscar Gruss & Son has not prepared, reviewed or distributed this material.Some of this material is produced by providers which Makor Securities believes to be reliable, but Makor Securities does not warrant or represent (expressly or impliedly) that it is accurate, complete, not misleading or as to its fitness for the purpose intended and it should not be relied upon as such.Opinions expressed will be the current opinions of those producing this material as of the date appearing on this material only. We expect those producing the material in this publication to update it on a timely basis but can give no undertaking that they will do so and regulatory compliance or other reasons may prevent them from doing so (or us from disseminating updated material).Members and employees of Makor Securities London Ltd, employees of Makor Capital, Makor Capital Markets may from time to time have long or short positions in securities, warrants, futures, options, derivatives or other financial instruments referred to in this material. For Makor Securities, this information is set out in our Conflicts of Interest Policy which is available on request. Policies for the production of research from other research providers are available on request. Unless otherwise stated, share prices provided within this material are as at the close of business on the day prior to the date of the material.Neither the whole nor any part of this material may be duplicated in any form or by any means. Neither should any of this material be redistributed or disclosed to anyone without prior consent. This material is issued for general information and discussion purposes only. None of Makor Securities, Makor Capital, Makor Capital Markets accepts liability whatsoever for any direct, indirect or consequential loss or damage of any kind arising out of the use of all or any of this material.The services, securities and investments discussed in this material may not be available to, nor are suitable for all investors. Investors should make their own investment decisions based upon their own financial objectives and financial resources and it should be noted that investment involves risk, including the risk of capital loss. Past performance is no guide to future performance. In relation to securities denominated in foreign currency, movements in exchange rates will have an effect on the value, either favourable or unfavourable.All investors. Investors should make their own investment decisions based upon their own financial objectives and financial resources and it should be noted that investment involves risk, including the risk of capital loss. Past performance is no guide to future performance. In relation to securities denominated in foreign currency, movements in exchange rates will have an effect on the value, either favourable or unfavourable.EntitiesMakor Securities London Ltd is authorised and regulated by the Financial ConductAuthority (FCA registration number 625054)Makor Capital, company number 514456466, is incorporated in Israel and is a 100% heldsubsidiary of Makor Holdings Pte Ltd incorporated in Singapore.Makor Capital Markets SA, company number CH-660.2.999.011-0 is incorporated in Switzerlandand is also a 100% held subsidiary of Makor Holdings Pte Ltd.
Having trouble viewing this email? Click here
This email was sent to lchekroun@makor-cm.com by Research@Makor-Capital.com
Update Profile/Email Address | Unsubscribe | Report abuse
Smoove email marketing